Creatine and Creatinine Metabolism - Physiological Reviews

1184 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
M. Wyss, F. Hoffmann-La Roche Ltd., Vitamins and Fine Chemicals
Division, Bldg. 241/865, CH-4070 Basel, Switzerland
(E-mail: markus.wyss@roche.com).
REFERENCES
1. AASERUD R, GRAMVIK P, OLSEN SR, AND JENSEN J. Creatine
supplementation delays onset of fatigue during repeated bouts of
sprint running. Scand J Med Sci Sports 8: 247–251, 1998.
2. ACHTEN E, BOON P, VAN DE KERCKHOVE T, CAEMAERT J, DE
REUCK J, AND KUNNEN M. Value of single-voxel proton MR
spectroscopy in temporal lobe epilepsy. Am J Neuroradiol 18:
1131–1139, 1997.
3. ADAMS GR AND BALDWIN KM. Age dependence of myosin heavy
chain transitions induced by creatine depletion in rat skeletal
muscle. J Appl Physiol 78: 368–371, 1995.
4. ADAMS GR, BODELL PW, AND BALDWIN KM. Running performance
and cardiovascular capacity are not impaired in creatinedepleted
rats. J Appl Physiol 79: 1002–1007, 1995.
5. ADAMS GR, HADDAD F, AND BALDWIN KM. Interaction of
chronic creatine depletion and muscle unloading: effects on postural
and locomotor muscles. J Appl Physiol 77: 1198–1205, 1994.
6. AIRED S, CREACH Y, PALEVODY C, ESCLASSAN J, AND HOL-
LANDE E. Creatine phosphate as energy source in the ceruleinstimulated
rat pancreas study by 31 P nuclear magnetic resonance.
Int J Pancreatol 10: 81–95, 1991.
7. AKAMATSU S AND KANAI Y. Bacterial decomposition of creatinine.
I. Creatinomutase. Enzymologia 15: 122–125, 1951.
8. AKAMATSU S AND MIYASHITA R. Bacterial decomposition of
creatine. III. The pathway of creatine decomposition. Enzymologia
15: 173–176, 1951.
9. AKSENOVA MV, AKSENOV MY, PAYNE RM, TROJANOWSKI JQ,
SCHMIDT ML, CARNEY JM, BUTTERFIELD DA, AND MARKES-
BERY WR. Oxidation of cytosolic proteins and expression of
creatine kinase BB in frontal lobe in different neurodegenerative
disorders. Dement Geriatr Cogn Disord 10: 158–165, 1999.
10. AL BANCHAABOUCHI M, MARESCAU B, D’HOOGE R, VAN
MARCK E, VAN DAELE A, LEVILLAIN O, AND DE DEYN PP.
Biochemical and histopathological changes in nephrectomized
mice. Metabolism 47: 355–361, 1998.
11. ALIEV MK, VAN DORSTEN FA, NEDERHOFF MG, VAN
ECHTELD CJA, VEKSLER V, NICOLAY K, AND SAKS VA. Mathematical
model of compartmentalized energy transfer: its use for
analysis and interpretation of 31 P-NMR studies of isolated heart of
creatine kinase deficient mice. Mol Cell Biochem 184: 209–229,
1998.
12. ALINK GM, KNIZE MG, SHEN NH, HESSE SP, AND FELTON JS.
Mutagenicity of food pellets from human diets in the Netherlands.
Mutat Res 206: 387–393, 1988.
13. ALLAM ME, HOUSER S, HASHMI F, LIU X, CORDIS GA, AND
ELGEBALY SA. Myocardial preservation by cyclocreatine: restoration
of postischemic myocardial contractility. Surg Forum XLI:
246–249, 1990.
14. ALLEN DG, MORRIS PG, ORCHARD CH, AND PIROLO JS. A
nuclear magnetic resonance study of metabolism in the ferret
heart during hypoxia and inhibition of glycolysis. J Physiol
(Lond) 361: 185–204, 1985.
15. ALSEVER RN, GEORG RH, AND SUSSMAN KE. Stimulation of
insulin secretion by guanidinoacetic acid and other guanidine
derivatives. Endocrinology 86: 332–336, 1970.
16. ALTSCHULD RA, GAMELIN LM, KELLEY RE, LAMBERT MR,
APEL LE, AND BRIERLEY GP. Degradation and resynthesis of
adenine nucleotides in adult rat heart myocytes. J Biol Chem 262:
13527–13533, 1987.
17. AMBROSIO G, JACOBUS WE, BERGMAN CA, WEISMAN HF, AND
BECKER LC. Preserved high energy phosphate metabolic reserve
in globally “stunned” hearts despite reduction of basal ATP content
and contractility. J Mol Cell Cardiol 19: 953–964, 1987.
18. AMBROSIO G, ZWEIER JL, AND FLAHERTY JT. The relationship
between oxygen radical generation and impairment of myocardial
energy metabolism following post-ischemic reperfusion. J Mol
Cell Cardiol 23: 1359–1374, 1991.
19. ANARI MR, JOSEPHY PD, HENRY T, AND O’BRIEN PJ. Hydrogen
peroxide supports human and rat cytochrome P-450 1A2-catalyzed
2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to
mutagenic metabolites: significance of cytochrome P-450 peroxygenase.
Chem Res Toxicol 10: 582–588, 1997.
20. ANDERSON D, BASARAN N, COBRZYNSKA MM, BASARAN AA,
AND YU T-W. Modulating effects of flavonoids on food mutagens in
human blood and sperm samples in the Comet assay. Teratogen
Carcinogen Mutagen 17: 45–58, 1997.
21. ANDO A, ORITA Y, NAKATA K, TSUBAKIHARA Y, TAKAMITSU
Y, UEDA N, YANASE M, AND ABE H. Effect of low protein diet and
surplus of essential amino acids on the serum concentration and
the urinary excretion of methylguanidine and guanidinosuccinic
acid in chronic renal failure. Nephron 24: 161–169, 1979.
22. ANDREWS R, GREENHAFF P, CURTIS S, PERRY A, AND COW-
LEY AJ. The effect of dietary creatine supplementation on skeletal
muscle metabolism in congestive heart failure. Eur Heart J 19:
617–622, 1998.
23. ANNESLEY TM AND WALKER JB. Cyclocreatine phosphate as a
substitute for creatine phosphate in vertebrate tissues. Energetic
considerations. Biochem Biophys Res Commun 74: 185–190,
1977.
24. ANNESLEY TM AND WALKER JB. Energy metabolism of skeletal
muscle containing cyclocreatine phosphate. J Biol Chem 255:
3924–3930, 1980.
25. AOYAGI K, AKIYAMA K, KUZURE Y, TAKEMURA K, NAGASE S,
IENAGA K, NAKAMURA K, KOYAMA A, AND NARITA M. Synthesis
of creatol, a hydroxyl radical adduct of creatinine and its
increase by puromycin aminonucleoside in isolated rat hepatocytes.
Free Radical Res 29: 221–226, 1998.
26. APPLE FS AND ROGERS MA. Mitochondrial creatine kinase activity
alterations in skeletal muscle during long-distance running.
J Appl Physiol 61: 482–485, 1986.
27. APPLEYARD G AND WOODS DD. The pathway of creatine catabolism
by Pseudomonas ovalis. J Gen Microbiol 14: 351–365, 1956.
28. ARA G, GRAVELIN LM, KADDURAH-DAOUK R, AND TEICHER
BA. Antitumor activity of creatine analogs produced by alterations
in pancreatic hormones and glucose metabolism. In Vivo 12:
223–232, 1998.
29. ARSTALL MA, BAILEY C, GROSS WL, BAK M, BALLIGAND J-L,
AND KELLY RA. Reversible S-nitrosation of creatine kinase by
nitric oxide in adult rat ventricular myocytes. J Mol Cell Cardiol
30: 979–988, 1998.
30. ARTRU AA AND MICHENFELDER JD. Cyclocreatine phosphate,
an analogue of creatine phosphate, does not improve hypoxic
tolerance in mice. J Neurochem 39: 1198–1200, 1982.
31. ASKANAS V, MCFERRIN J, BAQUÉ S, ALVAREZ RB, SARKOZI E,
AND ENGEL WK. Transfer of �-amyloid precursor protein gene
using adenovirus vector causes mitochondrial abnormalities in
cultured normal human muscle. Proc Natl Acad Sci USA 93:
1314–1319, 1996.
32. ASKENASY N AND KORETSKY AP. Differential effects of creatine
kinase isoenzymes and substrates on regeneration in livers of
transgenic mice. Am J Physiol Cell Physiol 273: C741–C746, 1997.
33. ATTARIAN DE, JONES RN, CURRIE WD, HILL RC, SINK JD,
OLSEN CO, CHITWOOD WR, AND WECHSLER AS. Characteristics
of chronic left ventricular hypertrophy induced by subcoronary
valvular aortic stenosis. I. Myocardial blood flow and metabolism.
J Thorac Cardiovasc Surg 81: 382–388, 1981.
34. ATTARIAN DE, JONES RN, CURRIE WD, HILL RC, SINK JD,
OLSEN CO, CHITWOOD WR, AND WECHSLER AS. Characteristics
of chronic left ventricular hypertrophy induced by subcoronary
valvular aortic stenosis. II. Response to ischemia. J Thorac Cardiovasc
Surg 81: 389–395, 1981.
35. AUFFERMAN W, WU ST, DERUGIN N, PARMLEY W, HIGGINS C,
KAPELKO V, AND WIKMAN-COFFELT J. 31 P magnetic resonance
spectroscopy of pressure overload hypertrophy in rats: effect of
reduced perfusion pressure. Cardiovasc Res 24: 57–64, 1990.
36. AUSTIN EA AND HUBER BE. A first step in the development of
gene therapy for colorectal carcinoma: cloning, sequencing, and
expression of Escherichia coli cytosine deaminase. Mol Pharmacol
43: 380–387, 1993.
37. AUSTRUY E, COHEN-SALMON M, ANTIGNAC C, BÉROUD